Unexpected Serologic Results Following DTT Treatment in Daratumumab Recipients
Publication
, Conference
Simmons, H; Poisson, JL; Bandarenko, N
Published in: TRANSFUSION
2022
Duke Scholars
Published In
TRANSFUSION
EISSN
1537-2995
ISSN
0041-1132
Publication Date
2022
Volume
62
Start / End Page
147A / 148A
Related Subject Headings
- Cardiovascular System & Hematology
- 3204 Immunology
- 3202 Clinical sciences
- 3201 Cardiovascular medicine and haematology
- 1107 Immunology
- 1103 Clinical Sciences
- 1102 Cardiorespiratory Medicine and Haematology
Citation
APA
Chicago
ICMJE
MLA
NLM
Simmons, H., Poisson, J. L., & Bandarenko, N. (2022). Unexpected Serologic Results Following DTT Treatment in Daratumumab Recipients. In TRANSFUSION (Vol. 62, pp. 147A-148A).
Simmons, Heather, Jessica L. Poisson, and Nicholas Bandarenko. “Unexpected Serologic Results Following DTT Treatment in Daratumumab Recipients.” In TRANSFUSION, 62:147A-148A, 2022.
Simmons H, Poisson JL, Bandarenko N. Unexpected Serologic Results Following DTT Treatment in Daratumumab Recipients. In: TRANSFUSION. 2022. p. 147A-148A.
Simmons, Heather, et al. “Unexpected Serologic Results Following DTT Treatment in Daratumumab Recipients.” TRANSFUSION, vol. 62, 2022, pp. 147A-148A.
Simmons H, Poisson JL, Bandarenko N. Unexpected Serologic Results Following DTT Treatment in Daratumumab Recipients. TRANSFUSION. 2022. p. 147A-148A.
Published In
TRANSFUSION
EISSN
1537-2995
ISSN
0041-1132
Publication Date
2022
Volume
62
Start / End Page
147A / 148A
Related Subject Headings
- Cardiovascular System & Hematology
- 3204 Immunology
- 3202 Clinical sciences
- 3201 Cardiovascular medicine and haematology
- 1107 Immunology
- 1103 Clinical Sciences
- 1102 Cardiorespiratory Medicine and Haematology